Events & Training for January 2018

Pre-Filled Syringes Europe 2018

17 January 2018 - 18 January 2018

Join the calendar event highlight for the medical device industry at Europe's leading 10th annual conference and exhibition on Pre-Filled Syringes when it returns to Central London on 17th and 18th January 2018. Pre-Filled Syringes Europe will once again provide a perfect platform to discuss new advancements and showcase the latest innovations to keep you at the forefront of a dynamic and booming market. What will the future of the pharmaceutical industry look like following an increase in the number of generics and biosimilars hitting the market; a trend in the rise of self-administered drugs and personalised medicine; and Britain’s recent decision to leave Europe? How will these changes affect the PFS industry? Building on the success of its sell-out global 2017 PFS series of events which saw 100+ attendees join shows in London, Boston and San Diego, the agenda for Pre-Filled Syringes Europe 2018 has been carefully tailored to arm you with the key requirements and tools to adapt to an ever-changing medical landscape in areas that are critical to those working within parenteral drug delivery and injectable devices. Featured Speakers: • Alphons Fakler, Group Head Risk Management, Novartis Pharma • Bettine Boltres, Technical Account Manager, West Pharmaceutical Services • Elizabeth Baker, Group Manager Licensing Division, MHRA • Marcel Mueller, Device Project Leader, Novartis • Cedric Gysel, Staff Device Engineer, Janssen • Carsten Worsoe, Principal Scientist, CMC Analytical Support, Novo Nordisk • Vikas Jaitely, Senior Manager CMC Regulatory Intelligence and Pharmaceutical Science, Merck • Susanne Joerg, Head of Formulation Development, Lonza • Orla Downes, Head of Business Development Unit, Barts Health Pharmaceuticals • Barry Knight, Device Program Lead, UCB Celltech • Sudeshna Dutta Ray, Senior Engineer, Advanced Device Technology and Innovation, Amgen • Alexander Jung, Senior Manager, Technology and Innovation, Drug Delivery and Devices, Boehringer Ingelheim • Christian Dechant, Primary Packaging Director, Boehringer Ingelheim

Copthorne Tara Hotel, Scarsdale Place, Kensington, London, UK

7th annual Pharmaceutical Microbiology

22 January 2018 - 23 January 2018

SMi’s 7th annual Pharmaceutical Microbiology UK conference will provide attendees essential indicators for Quality Assurance and Quality Control whilst presenting that latest information on protecting pharmaceutical and healthcare products from spoilage by microorganisms, and protecting patients and consumers. This year’s event will provide an in-depth overview of the function of the pharmaceutical microbiologist and what they need to know, from regulatory filing and GMP, to laboratory design and management, and risk assessment tools and techniques. These key aspects are discussed through a series of dedicated presentations, keynote sessions and workshops, with topics covering biofilms, validation, data analysis, bioburden, toxins, microbial identification, mycoplasma testing, and contamination control.

Holiday Inn Kensington Forum, London, UK

15th International Symposium on Hyphenated Techniques in Chromatography and Separation Technology

24 January 2018 - 26 January 2018

HTC-15 will be the premier conference in hyphenated separation techniques in 2018. With its rich history of successful meetings since 1990 HTC will be hosted at Cardiff City Hall in the heart of the capital city of Wales. The conference has always delivered presentations from internationally renowned experts both from Industry and Academia. The HTC 15 Event will be enhanced through joint chairing of the Scientific Committee by Tom Lynch and Peter Schoenmakers.

Cardiff City Hall, Wales, United Kingdom

Drug Discovery for Rare Diseases

28 March 2018

Rare diseases, or diseases that affect only a small percentage of the population, have been growing in significance and prominence in recent years. According to the National Institutes of Health, there are nearly 7000 rare diseases and more than 25 million Americans who are affected. Approximately 80% of these rare diseases are genetic in origin. Cambridge Healthtech Institute's symposium on Drug Discovery for Rare Diseases will bring together leading scientists, clinicians, executives and experts who are deeply involved in bringing to market the treatments for such rare disorders. This symposium will bring to light some of the new drug targets, and peptide and oligonucleotide-based drug modalities that are being pursued. This unique one-day event will bring together people from diverse backgrounds to tackle translational challenges and to discuss potential opportunities in this field. The goal is to help attendees and sponsors meet scientific and technical experts who are involved in rare disease research to exchange ideas and set up collaborations.

Boston Marriott, Cambridge, MA, USA